Vaccines highly effective against hospitalisation from Delta variant
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
New analysis by PHE shows for the first time that 2 doses of COVID-19 vaccines are highly effective against hospitalisation from the Delta (B.1.617.2) variant.
Further work remains underway to establish the level of protection against mortality from the Delta variant. However, as with other variants, this is expected to be high.
The analysis included 14,019 cases of the Delta variant – 166 of whom were hospitalised – between 12 April and 4 June, looking at emergency hospital admissions in England.
Public Health England (PHE) has previously published analysis showing that one dose is 17% less effective at preventing symptomatic illness from the Delta variant, compared to Alpha, but there is only a small difference after 2 doses.
If you have had your first dose but haven’t booked your second yet – please do so. It will help save lives and boost us on the road to recovery.
/cloudfront-us-east-2.images.arcpublishing.com/reuters/IUIUQZBMY5LZTBRO6IIF2Z4DH4.jpg)
